22 Results for "

EHMT

" in MedChemExpress (MCE) Product Catalog:
Products (22)

22 Results for "EHMT" in MCE Product Catalog:

12
12 Publications Verification
Cat. No.: HY-15273
CAS No.: 1255580-76-7
Purity:  99.48%
UNC0638, a chemical probe, selectively inhibits G9a and GLP histone methyltransferases with IC50 of 15 nM and 19 nM, respectively. UNC0638 inhibits TNBC cell invasion and migration in vitro. UNC0638 is also an inhibitor of EHMT1/2 and induces fetal hemoglobin (HbF) expression in human erythroid progenitor cell culture. In addition, UNC0638 has anti-FMDV (foot-and-mouth disease virus) and anti-VSV (vesicular stomatitis virus) activities, with excellent potency and selectivity against multiple epigenetic and non-epigenetic targets .
7
7 Cited Publications
Cat. No.: HY-12583
CAS No.: 1527503-11-2
Purity:  98.01%
A-366, a chemical probe, is a potent, highly selective, peptide-competitive histone methyltransferase G9a inhibitor with IC50s of 3.3 and 38 nM for G9a and GLP (EHMT1), respectively. A-366 shows >1000-fold selectivity over 21 other methyltransferases. A-366 is also a potent, nanomolar inhibitor of the Spindlin1-H3K4me3-interaction (IC50=182.6 nM). A-366 displays high affinity at human histamine H3 receptor (Ki=17 nM) and shows subtype selectivity among subsets of the histaminergic and dopaminergic receptor families .
Cat. No.: HY-111778
CAS No.: 2230849-55-3
Purity:  99.84%
Research Areas:  

Cancer

EHMT2-IN-1 is a potent EHMT inhibitor, with IC50s of all <100 nM for EHMT1 peptide, EHMT2 peptide and cellular EHMT2. Used in the research of blood disorder or cancer .
Cat. No.: HY-111904
CAS No.: 2230850-47-0
Purity:  ≥99.0%
Research Areas:  

Cancer

EHMT2-IN-2 is a potent EHMT inhibitor, with IC50s of all <100 nM for EHMT1 peptide, EHMT2 peptide and cellular EHMT2. Used in the research of blood disease or cancer .
Cat. No.: HY-161759
CAS No.: 3107476-89-8
Research Areas:  

Endocrinology Cancer

MS152 is an orally active, blood-brain barrier penetrant inhibitor of EHMT2/G9a and EHMT1/GLP, with IC50s of 76 nM and 126 nM, repsectively. MS152 reduces H3K9me2 levels and reactivates maternally silenced Prader-Willi syndrome (PWS) genes. MS152 significantly improves perinatal lethality and growth retardation in mouse models, and is applicable to research related to Prader-Willi syndrome .
Cat. No.: HY-44062
CAS No.: 1350752-07-6
Research Areas:  

Inflammation/Immunology Cancer

G9a-IN-1 (Compound 113) is a G9a protein inhibitor. G9A/EHMT2 is a nuclear histone lysine methyltransferase that catalyzes histone H3 lysine 9 dimethylation (H3K9me2), which is a reversible modification generally associated with transcriptional gene silencing. G9a-IN-1 can be used for the research of autoimmune disorders or cancer .
Cat. No.: HY-RS04227
Research Areas:  

Others

EHMT1 Human Pre-designed siRNA Set A contains three designed siRNAs for EHMT1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Cat. No.: HY-RS04228
Research Areas:  

Others

Ehmt1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Ehmt1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Cat. No.: HY-RS04229
Research Areas:  

Others

EHMT1 Rat Pre-designed siRNA Set A contains three designed siRNAs for EHMT1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Cat. No.: HY-RS04230
Research Areas:  

Others

EHMT2 Human Pre-designed siRNA Set A contains three designed siRNAs for EHMT2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Cat. No.: HY-RS04231
Research Areas:  

Others

Ehmt2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Ehmt2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Cat. No.: HY-RS04232
Research Areas:  

Others

Ehmt2 Rat Pre-designed siRNA Set A contains three designed siRNAs for Ehmt2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Cat. No.: HY-133031
CAS No.: 442150-41-6
Research Areas:  

Cancer

CSV0C018875 is a quinoline-based EHMT2/G9a inhibitor. CSV0C018875 exhibits lesser cytotoxicity than BIX-01294 .
Cat. No.: HY-110093
CAS No.: 1255517-77-1
UNC0638 hydrate selectively inhibits G9a and GLP histone methyltransferases with IC50 of 15 nM and 19 nM, respectively. UNC0638 hydrate inhibits TNBC cell invasion and migration in vitro. UNC0638 hydrate is also an inhibitor of EHMT1/2 and induces fetal hemoglobin (HbF) expression in human erythroid progenitor cell culture. In addition, UNC0638 hydrate has anti-FMDV (foot-and-mouth disease virus) and anti-VSV (vesicular stomatitis virus) activities, with excellent potency and selectivity against multiple epigenetic and non-epigenetic targets .
Cat. No.: HY-133031A
CAS No.: 474084-56-5
Research Areas:  

Others

CSV0C018875 hydrochloride is a G9a (EHMT2) inhibitor that inhibits G9a activity. CSV0C018875 can effectively inhibit G9a activity in both enzyme and cell-based assays, and its toxicity is much lower than that of the known G9a inhibitor BIX-01294. CSV0C018875 binds tightly to the active site cavity of G9a, thereby improving the binding firmness and prolonging the residence time of the compound, further enhancing the inhibitory effect of G9a. CSV0C018875 has the potential to improve its ADME (absorption, distribution, metabolism and excretion) and pharmacodynamic properties through further optimization .
Cat. No.: HY-P82628
Synonyms: Bat8; EHMT2; G9A; GAT8; NG36

Host:  

Rabbit

Application:  

WB, IHC-P

Reactivity:  

Human

Cat. No.: HY-183058
CAS No.: 2140164-84-5
Research Areas:  

Cancer

EZM8266 is an orally active and selective G9a (EHMT2) histone methyltransferase inhibitor with a human EHMT2 IC50 of 1 pM. EZM8266 reduces repressive H3K9me2 marks at immune-stimulatory gene and endogenous retroviral element promoters. EZM8266 reduces colony formation, migration, and invasion of cancer cells. EZM8266 enhances IFN-γ response, increases MHC class I expression, and enhances CXCL10-mediated T cell recruitment in cancer cells. EZM8266 can be used for the research of hepatocellular carcinoma .
Cat. No.: HY-P703636
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: EUHMTASE1; GLP; KIAA1876; KMT1D
Species:  
Source:  
Cat. No.: HY-P703635
Synonyms: EUHMTASE1; GLP; KIAA1876; KMT1D
Species:  
Source:  
Cat. No.: HY-P85132
Synonyms: EHMT1; EUHMTASE1; GLP; KIAA1876; KMT1D; Histone-lysine N-methyltransferase EHMT1; Euchromatic histone-lysine N-methyltransferase 1; Eu-HMTase1; G9a-like protein 1; GLP; GLP1; Histone H3-K9 methyltransferase 5; H3-K9-HMTase 5; Lysine N-methy

Host:  

Mouse

Application:  

WB, ELISA

Reactivity:  

Human